Loading...

PerCP/Cyanine5.5 anti-mouse F4/80 Antibody

Pricing & Availability
Clone
BM8 (See other available formats)
Regulatory Status
RUO
Other Names
EMR1, Ly71
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
BM8_PerCPCyanine55_F4-80_Antibody_010319
Thioglycolate-elicited Balb/c mouse peritoneal macrophages were stained with CD11b FITC and F4/80 (clone BM8) PerCP/Cyanine5.5 (left) or rat IgG2a, ? isotype control PerCP/Cyanine5.5 (right).
  • BM8_PerCPCyanine55_F4-80_Antibody_010319
    Thioglycolate-elicited Balb/c mouse peritoneal macrophages were stained with CD11b FITC and F4/80 (clone BM8) PerCP/Cyanine5.5 (left) or rat IgG2a, ? isotype control PerCP/Cyanine5.5 (right).
Compare all formats See PerCP/Cyanine5.5 spectral data
Cat # Size Price Quantity Check Availability Save
123127 25 µg 123€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
123128 100 µg 287€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

F4/80, also known as EMR1 or Ly71, is a 160 kD glycoprotein of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4/80 has been widely used as a murine macrophage marker. It is expressed on a majority of tissue macrophages, including macrophages in the lung, gut, peritoneal cavity, thymus, and red pulp of the spleen, Kupffer cells, Langerhans cells, microglia, and certain dendritic cells. It is not expressed on macrophages located in the T cell areas of the spleen, lymph node, or Peyer's patch. The biological ligand of F4/80 has not been identified, but it has been reported that F4/80 is required for the induction of CD8+ T cells-mediated peripheral tolerance.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Murine macrophages
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 1.0 µg per 106 cells in 100 µl. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, Western blotting, and spatial biology (IBEX)12,13.

Additional Product Notes
BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.
Application References
  1. Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC)
  2. Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC)
  3. Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed
  4. Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed
  5. Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed
  6. Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC)
  7. Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC)
  8. Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed
  9. Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed
  10. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
  11. Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Serra-Hassoun M, et al. 2014. J Immunol. 193:1504. PubMed
  2. Lin D, et al. 2016. Cancer Res . 76: 3179 - 3188. PubMed
  3. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  4. Tong CF, et al. 2018. Am J Physiol Cell Physiol. 315:C409. PubMed
  5. Jaitin DA, et al. 2020. Cell. 178(3):686-698.e14.. PubMed
  6. Bernasconi R, et al. 2021. EMBO Mol Med. :e14392. PubMed
  7. Correa S, et al. 2020. ACS Nano. 14:2224. PubMed
  8. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  9. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  10. Kaku H, et al. 2014. J Immunol. 193:5904. PubMed
  11. Li Q, et al. 2019. Neuron. 101:207. PubMed
  12. Hulsebus HJ, et al. 2022. Front Immunol. 13:884719. PubMed
  13. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  14. Balog S, et al. 2020. Hepatology. 71:291. PubMed
  15. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  16. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  17. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  18. Tyagi AM et al. 2018. Immunity. 49(6):1116-1131 . PubMed
  19. Deslyper G, et al. 2021. Parasitology. 148:539. PubMed
  20. Si Y, et al. 2020. Sci Adv. 6:eaba0995. PubMed
  21. Thompson PJ et al. 2019. Cell metabolism. 29(5):1045-1060 . PubMed
  22. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  23. Jones N, et al. 2021. Nat Commun. 12:1209. PubMed
  24. Mul Fedele ML, et al. 2020. Front Cell Infect Microbiol. 10:100. PubMed
  25. Brykczynska U, et al. 2020. Cell Reports. 30(5):1627-1643.e7.. PubMed
  26. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  27. Saint Fleur–Lominy S, et al. 2018. Cell Rep. 24:3045. PubMed
  28. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  29. Zhang P, et al. 2022. BMC Med. 20:435. PubMed
  30. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  31. Zellweger R, et al. 2010. Cell Host Microbe. 18:128. PubMed
  32. Wang F, et al. 2018. Carcinogenesis. 39:889. PubMed
  33. Si Y, et al. 2018. J Control Release. 282:120. PubMed
  34. Pitsch J, et al. 2021. Ann Neurol. 89:666. PubMed
  35. McFarland AP, et al. 2021. Immunity. 54(6):1320-1337.e4. PubMed
  36. Garg M, et al. 2021. Cell Reports. 34(6):108736. PubMed
  37. Chen Z, et al. 2015. Am J Physiol Endocrinol Metab. 308:460. PubMed
  38. Boehm DT, et al. 2018. Infect Immun. 86:. PubMed
  39. Jiang W, et al. 2021. J Cell Physiol. 236:7711. PubMed
  40. Brandi P, et al. 2022. Cell Rep. 38:110184. PubMed
  41. Momin N, et al. 2022. Nat Commun. 13:109. PubMed
  42. Kren N, et al. 2020. Sci Rep. 10:7390. PubMed
  43. Vogel AB, et al. 2021. Nature. 592:283. PubMed
  44. Macdougall CE et al. 2018. Cell metabolism. 27(3):588-601 . PubMed
  45. Longenecker JZ, et al. 2021. Mol Metab. 54:101343. PubMed
  46. Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed
  47. Huang D, et al. 2020. Nat Commun. 4.520833333. PubMed
  48. Lim S, et al. 2016. PLoS One. 11: 0155689. PubMed
  49. Sztwiertnia I, et al. 2020. PLoS One. 15:e0233789. PubMed
  50. Song P, et al. 2018. Int J Mol Med. 41:935. PubMed
  51. Bachy S, et al. 2022. iScience. 25:103758. PubMed
  52. RY H, et al. 2016. Oncoimmunology. 6:e1249561. PubMed
  53. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  54. Duan H et al. 2018. Immunity. 49(2):301-311 . PubMed
  55. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  56. Traboulsi H, et al. 2015. Antimicrob Agents Chemother. 59: 6317. PubMed
  57. Chou H, et al. 2015. Proc Natl Acad Sci U S A. 112:2175. PubMed
  58. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  59. Chen X, et al. 2021. Immunity. 54(2):324-339.e8. PubMed
  60. Meunier I, et al. 2015. PLoS One. 10: 0138055. PubMed
  61. Watson N, et al. 2015. J Immunol. 194:2796. PubMed
  62. Buerfent BC, et al. 2019. GMS Infect Dis. 7:Doc04. PubMed
  63. Wu M, et al. 2020. Mucosal Immunol. 13:47. PubMed
  64. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  65. Howard ZM, et al. 2021. Am J Pathol. 191:730. PubMed
  66. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  67. Zhang X, et al. 2020. Arterioscler Thromb Vasc Biol. 40:597. PubMed
  68. Lisk C, et al. 2021. Front Immunol. 12:624197. PubMed
  69. Sobecki M, et al. 2022. Cell Stem Cell. 29:1459. PubMed
  70. Kunishita Y, et al. 2020. Front Immunol. 11:98. PubMed
  71. Chen X, et al. 2022. STAR Protoc. 3:101180. PubMed
  72. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  73. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  74. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  75. Hwang BJ, et al. 2022. J Immunother Cancer. 10:. PubMed
  76. Kim SH, et al. 2020. Neoplasia. 1.3375. PubMed
  77. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  78. Rodrigues TS, et al. 2020. J Leukoc Biol. 108:1225. PubMed
  79. Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed
  80. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  81. Koda S, et al. 2021. Front Immunol. 12:754208. PubMed
RRID
AB_893496 (BioLegend Cat. No. 123127)
AB_893484 (BioLegend Cat. No. 123128)

Antigen Details

Structure
EGF-TM7 family member, 160 kD glycoprotein
Distribution

Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kupffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells

Function
Induction of immunological tolerance
Cell Type
Dendritic cells, Langerhans cells, Macrophages, Tregs
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Antigen References

1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805.
2. Hume DA, et al. 1983. J. Exp. Med. 158:1522.
3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801.
4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486.
5. Lin HH, et al. 2005. J. Exp. Med. 201:1615.

Gene ID
13733 View all products for this Gene ID
UniProt
View information about F4/80 on UniProt.org

Related FAQs

How stable is PerCP/Cyanine5.5 tandem as compared to PerCP alone?

PerCP/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.

Go To Top Version: 3    Revision Date: 01/03/2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account